These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38355986)

  • 101. A Systematic Review of Real-Time Deep Learning Methods for Image-Based Cancer Diagnostics.
    Sriraman H; Badarudeen S; Vats S; Balasubramanian P
    J Multidiscip Healthc; 2024; 17():4411-4425. PubMed ID: 39281299
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Artificial intelligence: A transformative tool in precision oncology.
    McGale J; Liao MJ; Lopci E; Marabelle A; Dercle L
    Oncotarget; 2024 Aug; 15():588-589. PubMed ID: 39186000
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Integrating Artificial Intelligence and PET Imaging for Drug Discovery: A Paradigm Shift in Immunotherapy.
    McGale JP; Howell HJ; Beddok A; Tordjman M; Sun R; Chen D; Wu AM; Assi T; Ammari S; Dercle L
    Pharmaceuticals (Basel); 2024 Feb; 17(2):. PubMed ID: 38399425
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Artificial Intelligence and Radiomics: Clinical Applications for Patients with Advanced Melanoma Treated with Immunotherapy.
    McGale J; Hama J; Yeh R; Vercellino L; Sun R; Lopci E; Ammari S; Dercle L
    Diagnostics (Basel); 2023 Sep; 13(19):. PubMed ID: 37835808
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Artificial Intelligence in Breast Cancer: A Systematic Review on PET Imaging Clinical Applications.
    Alongi P; Rovera G; Stracuzzi F; Popescu CE; Minutoli F; Arnone G; Baldari S; Deandreis D; Caobelli F
    Curr Med Imaging; 2023; 19(8):832-843. PubMed ID: 36703586
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Artificial intelligence in immunotherapy PET/SPECT imaging.
    McGale JP; Chen DL; Trebeschi S; Farwell MD; Wu AM; Cutler CS; Schwartz LH; Dercle L
    Eur Radiol; 2024 Sep; 34(9):5829-5841. PubMed ID: 38355986
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Ethnic diversity in treatment response for colorectal cancer: proof of concept for radiomics-driven enrichment trials.
    Dercle L; Yang M; Gönen M; Flynn J; Moskowitz CS; Connors DE; Yang H; Lu L; Reidy-Lagunes D; Fojo T; Karovic S; Zhao B; Schwartz LH; Henick BS
    Eur Radiol; 2023 Dec; 33(12):9254-9261. PubMed ID: 37368111
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Towards evidence-based response criteria for cancer immunotherapy.
    Garralda E; Laurie SA; Seymour L; de Vries EGE
    Nat Commun; 2023 May; 14(1):3001. PubMed ID: 37225715
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Artificial intelligence and radiomics: fundamentals, applications, and challenges in immunotherapy.
    Dercle L; McGale J; Sun S; Marabelle A; Yeh R; Deutsch E; Mokrane FZ; Farwell M; Ammari S; Schoder H; Zhao B; Schwartz LH
    J Immunother Cancer; 2022 Sep; 10(9):. PubMed ID: 36180071
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Radiation and immune checkpoint inhibitor-mediated pneumonitis risk stratification in patients with locally advanced non-small cell lung cancer: role of functional lung radiomics?
    Thomas HMT; Hippe DS; Forouzannezhad P; Sasidharan BK; Kinahan PE; Miyaoka RS; Vesselle HJ; Rengan R; Zeng J; Bowen SR
    Discov Oncol; 2022 Sep; 13(1):85. PubMed ID: 36048266
    [TBL] [Abstract][Full Text] [Related]  

  • 111. The expanding role for small molecules in immuno-oncology.
    Offringa R; Kötzner L; Huck B; Urbahns K
    Nat Rev Drug Discov; 2022 Nov; 21(11):821-840. PubMed ID: 35982333
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Assessing dynamic metabolic heterogeneity in non-small cell lung cancer patients via ultra-high sensitivity total-body [
    Wang D; Zhang X; Liu H; Qiu B; Liu S; Zheng C; Fu J; Mo Y; Chen N; Zhou R; Chu C; Liu F; Guo J; Zhou Y; Zhou Y; Fan W; Liu H
    Eur J Nucl Med Mol Imaging; 2022 Nov; 49(13):4692-4704. PubMed ID: 35819498
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Computer-aided detection and segmentation of malignant melanoma lesions on whole-body
    Dirks I; Keyaerts M; Neyns B; Vandemeulebroucke J
    Comput Methods Programs Biomed; 2022 Jun; 221():106902. PubMed ID: 35636357
    [TBL] [Abstract][Full Text] [Related]  

  • 114. A Machine Learning Model Based on PET/CT Radiomics and Clinical Characteristics Predicts Tumor Immune Profiles in Non-Small Cell Lung Cancer: A Retrospective Multicohort Study.
    Tong H; Sun J; Fang J; Zhang M; Liu H; Xia R; Zhou W; Liu K; Chen X
    Front Immunol; 2022; 13():859323. PubMed ID: 35572597
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Prognostic Value of Radiomic Features of
    Zhou Y; Li J; Zhang X; Jia T; Zhang B; Dai N; Sang S; Deng S
    Front Oncol; 2022; 12():834288. PubMed ID: 35198451
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Toward Generalizability in the Deployment of Artificial Intelligence in Radiology: Role of Computation Stress Testing to Overcome Underspecification.
    Eche T; Schwartz LH; Mokrane FZ; Dercle L
    Radiol Artif Intell; 2021 Nov; 3(6):e210097. PubMed ID: 34870222
    [TBL] [Abstract][Full Text] [Related]  

  • 117. A Novel Approach Using FDG-PET/CT-Based Radiomics to Assess Tumor Immune Phenotypes in Patients With Non-Small Cell Lung Cancer.
    Zhou J; Zou S; Kuang D; Yan J; Zhao J; Zhu X
    Front Oncol; 2021; 11():769272. PubMed ID: 34868999
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Radiomics of
    Mu W; Tunali I; Qi J; Schabath MB; Gillies RJ
    Radiol Artif Intell; 2020 Jan; 2(1):e190063. PubMed ID: 33937811
    [TBL] [Abstract][Full Text] [Related]  

  • 119.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 120.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.